Abstract: Disclosed is a linear motor, including a mover and a stator which cooperate with each other. The mover includes mover iron cores arranged at intervals in a movement direction of the mover, and the stator includes permanent magnets arranged at intervals in the movement direction. Each of the mover iron cores includes an iron core yoke portion and an iron core tooth unit joined to each other. The iron core tooth unit defines an opening, and each of the permanent magnets is located at least partially within the opening.

Abstract: A method for measuring drop time of a control rod cluster integrated with a rod position measurement device is provided, wherein the method is used to measure the drop time of each control rod cluster, and includes: Si, monitoring a voltage Ua of coils in Group A to capture a rod cluster drop signal; S2, searching a point (tmax, Vmax) with a maximum drop speed or with a local maximum drop speed; S3, retroactively calculating, from tmax, an end of a time period T4 when the control rod cluster starts to drop; S4, retroactively searching, from a minimum value point of a drop reference signal DROPref, a start of the time period T4 when the drop reference signal DROPref drops from a maximum value to 33% thereof; and S5, determining, from tmax forward, a time point t6 when a drop speed of the control rod cluster is lower than 0.

Abstract: An amphibious robot includes a housing including a first shell and a second shell and having a first configuration and a second configuration, a rack disposed in an inner cavity of the housing, a telescopic assembly disposed on the rack and connected between the first shell and the second shell, and a rotary wing assembly disposed on the rack and having a folded configuration and a flight configuration. The rotary wing assembly includes: a folding arm with one end rotatably connected to the rack, a rotary wing, and a tilting arm connected between the rotary wing and the folding arm, the tilting arm and the rotary wing are extended to an outside of the housing to be adapted to drive the robot to fly in the flight configuration, and the tilting arm is rotatable relative to the folding arm to adjust a rotation direction of the rotary wing.

Abstract: An automatic wet washing and dry brushing apparatus for dogs comprises an elongated container, a tub placed inside the container at one end, a movable brush panel on each side of the tub and a mechanical device that drives the brush panels. The mechanical device is installed in the space between the container walls and the tub walls. The tub has two sidewalls, a floor with a drain, and a door at one end. Each brush panel is suspended on a sidewall and supported by a rail affixed inside the sidewall through a slot on the sidewall. The brush panels are used to brush a dog by sliding in a reciprocating motion. The brushes are made of spaced long and flexible bristles that accommodate the dog's body shape. The tub is equipped with water sprayers and a drain system. The container is movable with 4 wheels.

Abstract: An automatic wet washing and dry brushing apparatus for dogs comprises an elongated container, a tub placed inside the container at one end, a movable brush panel on each side of the tub and a mechanical device that drives the brush panels. The mechanical device is installed in the space between the container walls and the tub walls. The tub has two sidewalls, a floor with a drain, and a door at one end. Each brush panel is suspended on a sidewall and supported by a rail affixed inside the sidewall through a slot on the sidewall. The brush panels are used to brush a dog by sliding in a reciprocating motion. The brushes are made of spaced long and flexible bristles that accommodate the dog's body shape. The tub is equipped with water sprayers and a drain system. The container is movable with 4 wheels.

Abstract: An automatic washing apparatus for dogs and alike animals comprises a washing tub, a brushing plate and a horizontally movable carrier board on each side of the tub. Each brushing plate is attached to a vertically movable crank slider through horizontal extension arms. Each crank slider is motorized by a motor and situated on a carrier board. The carrier boards are mobilized by a low speed motor through pulleys, a timing belt, and wheels on rails. The movement is guided by a guiding rail. The tub includes a door and a drain on the floor and a wastewater compartment beneath the floor. The brushing plates and carrier boards are enclosed under two side covers. The apparatus further provides a water spraying system including spraying tubings, a water tank and a water pump.

Abstract: An automatic washing apparatus for dogs and alike animals comprises a washing tub, a brushing plate and a horizontally moving carrier board on each side of the tub. Each brushing plate is attached to a vertically moving crank slider through horizontal extension arms. Each crank slider is motorized by a motor and situated on a carrier board. In other embodiments the brush plates are driven by other mechanical mechanisms such as Scotch Yoke, Whitworth quick return, cam slider, reciprocating gear rack or rotation to rotation mechanisms using gears or pulleys and belts. The carrier boards are mobilized through pulley and belt, and wheels on rails. The movement is guided by a guiding rail. The tub includes a door and a drain on the floor and a waste water compartment beneath the floor. The brushing plates and carrier boards are enclosed under two side covers. The apparatus further provides a water spraying system including spraying tubings, a water tank and a water pump.

Abstract: The present invention pertains to novel uses of glycyrrhetinic acid (GA), glycyrrhizic acid (GLA) and related compounds for prevention and/or treatment of pulmonary fibrosis, in particular, irradiation-induced pulmonary fibrosis. Also embodied are therapeutic uses of prodrugs, metabolites, derivatives (e.g., acids, esters and ethers), and salts of glycyrrhetinic acid (GA) and glycyrrhizic acid (GLA). The present invention also provides for therapeutic or pharmaceutical compositions comprising a compound of the invention in a form that can be combined with a pharmaceutically acceptable carrier.

Abstract: The present invention pertains to novel uses of glycyrrhetinic acid (GA), glycyrrhizic acid (GLA) and related compounds for prevention and/or treatment of pulmonary fibrosis, in particular, irradiation-induced pulmonary fibrosis. Also embodied are therapeutic uses of prodrugs, metabolites, derivatives (e.g., acids, esters and ethers), and salts of glycyrrhetinic acid (GA) and glycyrrhizic acid (GLA). The present invention also provides for therapeutic or pharmaceutical compositions comprising a compound of the invention in a form that can be combined with a pharmaceutically acceptable carrier.

Abstract: The present invention discloses a composition comprising a ginseng product, a mucoadhesive and a mucosa penetration enhancer in an aqueous biodegradable block copolymer solution consisting of a 3-arm polyethylene glycol (PEG) and 3 polyesters chains, each of which extends on each of the arm of the 3-arm PEG. The invention also provides a method for transmucosal delivery of pharmaceuticals and nutraceutical such as ginsenosides with improved absorption and bioavailability.

Abstract: Substituted isothiazole compounds and compositions are provided, wherein particularly preferred compositions and methods are directed towards inhibition of various protein kinases (especially MEK and/or ERK). Consequently, particularly preferred methods include treatment of diseases associated with abnormality in MEK and/or ERK function.

Abstract: Substituted isothiazole compounds and compositions are provided, wherein particularly preferred compositions and methods are directed towards inhibition of various protein kinases (especially MEK and/or ERK). Consequently, particularly preferred methods include treatment of diseases associated with abnormality in MEK and/or ERK function.

Abstract: The use of triterpensaponins, like notoginsenoside R1 (NR1) and/or astragaloside (ASIV) for the production of medicaments for stimulating the fibrinolytic activity and blocking the endotoxin effect, especially for the treatment of patients and animals which suffer from endotoxin shock or to limit the endotoxin shock. Corresponding medicaments are also suitable prophylactive and therapeutic treatment of patients of coronary heart disease, peripheral arterial disease for patients who suffer from angina pectoris and for the prevention of such diseases in healthy persons.